SparingVision
Marie Uguen currently serves as the Chief Regulatory & Quality Officer and Senior Vice President of Regulatory Affairs & Quality Assurance at SparingVision, a position held since June 2023. Prior to this, Marie Uguen was the Chief Regulatory Officer & QA at LYSOGENE from April 2019 to June 2023. Marie Uguen's experience in regulatory science spans over 15 years at Voisin Consulting Life Sciences (VCLS), where roles included Senior Director for Regulatory Science, Drugs & Biologics. Academic credentials include a Master of Science from Institut national agronomique Paris-Grignon and Ecole Nationale Supérieure Agronomique de Toulouse, as well as a PhD in pharmacology from CNRS.
This person is not in any offices
SparingVision
SparingVision is a biotechnology company focused on the discovery and development of innovative therapies for the treatment of blinding inherited retinal diseases. SparingVision is developing SPVN06, a gene-independent drug candidate to treat retinitis pigmentosa, the most common inherited retinal degeneration.